Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
mozistobart zoratolimod (TAC-001)
i
Other names:
TAC-001, TAC 001
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Tallac Therap
Drug class:
TLR9 agonist, CD22 inhibitor
Related drugs:
‹
CMP-001 (3)
DV281 (1)
AST-008 (1)
SD-101 (1)
ALTA-002 (0)
GNKG168 (0)
DUET-101 (0)
DUET-201 (0)
ODN2395 (0)
agatolimod (0)
TAC-003 (0)
MGN1703 (0)
PG545 (0)
IMO-2125 (0)
BL-22 (0)
Imtox19/Imtox22 (0)
epratuzumab (0)
IgG-RFB4-SMPT-dgA (0)
epratuzumab Y-90 (0)
REGN5837 (0)
YT-19/22 (0)
anti CD19/CD22 CAR NK cells (0)
JNJ-8780 (0)
CMP-001 (3)
DV281 (1)
AST-008 (1)
SD-101 (1)
ALTA-002 (0)
GNKG168 (0)
DUET-101 (0)
DUET-201 (0)
ODN2395 (0)
agatolimod (0)
TAC-003 (0)
MGN1703 (0)
PG545 (0)
IMO-2125 (0)
BL-22 (0)
Imtox19/Imtox22 (0)
epratuzumab (0)
IgG-RFB4-SMPT-dgA (0)
epratuzumab Y-90 (0)
REGN5837 (0)
YT-19/22 (0)
anti CD19/CD22 CAR NK cells (0)
JNJ-8780 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login